Harry J Leonhardt insider trades: Amylin Pharmaceuticals (AMLN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Harry reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 1, 2012 | AMLN | ↓ Sell | 1,231 | $17.11 | $21K | Direct | Mar 2, 2012 (1d) |
| Feb 23, 2012 | AMLN | ↓ Sell | 2,180 | $17.03 | $37K | Direct | Feb 24, 2012 (1d) |
| Sep 4, 2007 | SNMX | ↓ Sell | 228 | $13.25 | $3K | Direct | Sep 4, 2007 (0d) |
| Jul 16, 2007 | SNMX | ↓ Sell | 1,500 | $13.64 | $20K | Direct | Jul 16, 2007 (0d) |
| Jun 15, 2007 | SNMX | ↓ Sell | 10,500 | $14.84 | $156K | Direct | Jun 18, 2007 (3d) |
| May 15, 2007 | SNMX | ↓ Sell | 1,500 | $12.47 | $19K | Direct | May 15, 2007 (0d) |
| Apr 16, 2007 | SNMX | ↓ Sell | 4,752 | $13.08 | $62K | Direct | Apr 17, 2007 (1d) |
| Feb 15, 2007 | SNMX | ↓ Sell | 1,500 | $12.73 | $19K | Direct | Feb 16, 2007 (1d) |
| Jan 16, 2007 | SNMX | ↓ Sell | 1,500 | $12.83 | $19K | Direct | Jan 17, 2007 (1d) |
| Dec 15, 2006 | SNMX | ↓ Sell | 1,500 | $13.54 | $20K | Direct | Dec 18, 2006 (3d) |
| Nov 15, 2006 | SNMX | ↓ Sell | 3,000 | $14.88 | $45K | Direct | Nov 16, 2006 (1d) |
| Sep 15, 2006 | SNMX | ↓ Sell | 2,500 | $15.04 | $38K | Direct | Sep 18, 2006 (3d) |
| Sep 1, 2006 | SNMX | ↓ Sell | 954 | $14.96 | $14K | Direct | Sep 5, 2006 (4d) |
| Aug 15, 2006 | SNMX | ↓ Sell | 1,000 | $13.41 | $13K | Direct | Aug 15, 2006 (0d) |
| Jul 17, 2006 | SNMX | ↓ Sell | 1,000 | $13.11 | $13K | Direct | Jul 17, 2006 (0d) |
| Jun 15, 2006 | SNMX | ↓ Sell | 1,000 | $12.65 | $13K | Direct | Jun 16, 2006 (1d) |
| May 15, 2006 | SNMX | ↓ Sell | 1,000 | $12.78 | $13K | Direct | May 15, 2006 (0d) |
| Apr 17, 2006 | SNMX | ↓ Sell | 1,000 | $14.58 | $15K | Direct | Apr 18, 2006 (1d) |
| Mar 15, 2006 | SNMX | ↓ Sell | 2,000 | $15.78 | $32K | Direct | Mar 16, 2006 (1d) |
| Mar 1, 2006 | SNMX | ↓ Sell | 4,166 | $16.43 | $68K | Direct | Mar 2, 2006 (1d) |
| Feb 15, 2006 | SNMX | ↓ Sell | 9,520 | $15.50 | $148K | Direct | Feb 16, 2006 (1d) |
| Sep 15, 2005 | SNMX | ↓ Sell | 1,880 | $17.85 | $34K | Direct | Sep 16, 2005 (1d) |
| Jul 26, 2005 | SNMX | ↓ Sell | 3,212 | $21.16 | $68K | Direct | Jul 27, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Harry J Leonhardt's insider trades
Harry J Leonhardt is SVP, Legal, Compl & Corp Secty at Amylin Pharmaceuticals (AMLN). Since Jul 26, 2005, Harry has reported no open-market purchases and 23 sales worth $889K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), shares withheld for taxes (13 filings), option exercises (10 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.